-
1 Comment
CGN Nuclear Technology Development Co., Ltd is currently in a long term downtrend where the price is trading 0.6% below its 200 day moving average.
From a valuation standpoint, the stock is 66.4% cheaper than other stocks from the Industrials sector with a price to sales ratio of 1.7.
CGN Nuclear Technology Development Co., Ltd's total revenue rose by 0.4% to $2B since the same quarter in the previous year.
Its net income has increased by 92.7% to $55M since the same quarter in the previous year.
Finally, its free cash flow fell by 492.3% to $-198M since the same quarter in the previous year.
Based on the above factors, CGN Nuclear Technology Development Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000842 |
| Sector | Industrials |
| Industry | Conglomerates |
| PE Ratio | None |
|---|---|
| Target Price | 8.5 |
| Beta | 0.62 |
| Market Cap | 7B |
| Dividend Yield | None |
CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000881.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
